课题基金 / 基金详情

Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach

Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach
使用混合方法制定干预措施,以改善安全网人群中异常粪便免疫化学检测结果的随访
批准号:
10601330
负责人:
Rachel B. Issaka
金额:
$8.51万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2024-08-31

项目摘要

项目成果

Rachel B. Issaka的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Rachel Issaka, MD, MAS’ long-term career goal is to become an independent researcher and leader in developing, implementing, and evaluating interventions to reduce colorectal cancer (CRC) mortality in medically underserved populations. She has identified improving follow-up of abnormal fecal immunochemical test (FIT) results as a critical issue to address to achieve this goal. This proposal describes a 5-year comprehensive program of training and mentored research for an academic career in health outcomes research. The research agenda is in line with one of NCI’s five scientific goals: to improve cancer prevention and control. In this goal, advancing health care equity in medically underserved populations is an area of special focus. While Dr. Issaka has a strong background in clinical gastroenterology and safety-net systems-level research, this K08 will provide key training in advanced multilevel statistical modeling, qualitative research methods, mixed methods research, and intervention development. FIT is promoted over colonoscopy for CRC screening in federally qualified health centers (FQHCs) and safety-net health systems due to patient preference and limited colonoscopy resources. For FIT-based screening to effectively reduce CRC-mortality, abnormal results must be followed by a diagnostic colonoscopy. However, FQHCs and safety-net health systems do not consistently track follow-up of abnormal FIT results and failure to complete a diagnostic colonoscopy increases CRC-mortality by up to 3-fold. Research suggests approximately 50% of safety-net patients with an abnormal FIT do not complete a diagnostic colonoscopy within 1 year of their result. This highlights the importance of identifying and describing the barriers to diagnostic colonoscopy completion after abnormal FIT results in order to develop effective interventions. The study’s specific aims are: (1) using mixed methods, identify the potentially modifiable patient, provider, and clinic- level barriers to diagnostic colonoscopy in patients with abnormal FIT results in a large safety-net health system; and (2) based upon intervention targets identified in Aim 1, develop a pilot intervention to improve diagnostic colonoscopy completion in a safety-net population with abnormal FIT results. Dr. Issaka’s mentorship team including world-renowned gastroenterologists, health services researchers, qualitative and mixed methods experts and implementation scientists will provide experiential guidance to complement her didactic training. These factors in addition to the supportive research environments at the Fred Hutchinson Cancer Research Center and the University of Washington, will enable her to achieve the proposed project aims. Upon completion of the proposed research and training, Dr. Issaka will submit a competitive R-level grant application to test the pilot intervention in a randomized trial and will possess the skills and experience to make sustained and impactful contributions to reduce CRC-mortality through evidence-based interventions that improve follow-up of abnormal FIT results.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach
Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach
  • 批准号:
    10472516
  • 项目类别:
  • 资助金额:
    $22.57万
  • 财政年份:
    2019
  • 负责人:
    Rachel B. Issaka
  • 依托单位:
Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach
  • 批准号:
    10684912
  • 项目类别:
  • 资助金额:
    $22.36万
  • 财政年份:
    2019
  • 负责人:
    Rachel B. Issaka
  • 依托单位:
国内基金
海外基金
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
  • 批准号:
    82372743
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈卓佳
  • 依托单位:
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
  • 批准号:
    82371248
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    吴逸雯
  • 依托单位:
环境抗雄激素干预AR/TGFB1I1致尿道下裂血管内皮细胞发育异常的机制及其“预警信号”在早期诊断中的价值
  • 批准号:
    82371605
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    蒋君涛
  • 依托单位:
弓状核介导慢性疼痛引起动机下降的神经环路机制及rTMS干预研究
  • 批准号:
    82371536
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    张松
  • 依托单位: